Studies of the resistance patterns to infection with a murine cytomegalovirus in inbred strains of mice revealed the existence of resistant and susceptible strains. Resistance was found to be associated with possession of the H-2 k allele at the major histocompatibility locus of the mouse. The F 1 hybrid between a resistant strain (C3H/HeJ) and a susceptible strain (BALB/c) was found to have a resistance intermediate between that of both parents, indicating that the gene(s) controlling resistance is partly dominant. Susceptible BALB/c mice could be made resistant to lethal infection by pre-treatment with thioglycollate broth but not by pre-treatment with endotoxin or BCG. Resistant C3H]HeJ mice could be made susceptible to lethal infection by pre-treatment with cyclophosphamide.
INTRODUCTION
Cytomegaloviruses have been shown to suppress humoral (Osborn & Medearis, I967; Howard & Najarian, 1974) , cell-mediated (Howard, Miller & Najarian, I974) , and interferon (Osborn & Medearis, I966, I967) responses of the host to other antigens. Less is known however about the effect of these host responses on controlling infection by cytomegaloviruses. The purpose of this work was to examine the mechanisms of resistance of mice to cytomegalovirus. It was hoped that strains of mice with marked differences in susceptibility to murine cytomegalovirus (MCMV) could be used as tools in these investigations. Selgrade & Osborn (I974) had noted that there were differences in susceptibility to MCMV amongst one outbred and two inbred strains of mice in their studies. In this study seven inbred strains of mice were screened for resistance to murine cytomegalovirus and the genetics of resistance was further studied in some of these strains. In addition, congenic strains of mice were used in an attempt to locate the gene(s) coding for resistance, and immunosuppressive and immunostimulatory agents were also used to examine differences in murine susceptibility.
METHODS

Mice.
The following inbred strains of mice were obtained from the Perth Medical Centre Animal Breeding Unit, Perth, Western Australia: BALB/c, C57BL, C3H/HeJ, CBA, DK-BLACK, Simpson and Prince Henry Inbred. In addition, congenic strains of BALB/c mice carrying H-2 b, H-2g, or H-2 ~ alleles rather than the normal H-2 d allele were obtained from The Walter and Eliza Hall Institute, Melbourne, Australia. Both male and female mice were used. Mice used in experiments were 6 to i2 weeks old as indicated. Mice used for growing virus stocks were 19 to 22 days old.
Virus. The Smith strain of MCMV (obtained from Dr D. J. Lang, Duke University, Carolina, U.S.A.) was used in all experiments. Virus was given intraperitoneally to 19-to 22-day-old BALB/c or C3H/HeJ mice and was harvested from the salivary glands 2 to 4 weeks later. A IO to 20 % homogenate of the salivary glands was made in medium 199 (Grand Island Biological Company, New York) adjusted to mouse osmolarity (333 milliosmol) and supplemented with 25 mM-HEPES buffer and IO % foetal calf serum (FCS; Commonwealth Serum Laboratories, Melbourne, Victoria, Australia). Virus stocks were stored in gas phase nitrogen without stabilizers and were used within I month of harvesting. There was no apparent loss oftitre in this time. Infectivity of virus stocks was assessed in adult BALB/c mice to determine a 'minimum lethal dose' or by plaque assay.
Cellculture. Mouse embryo culture (MECC) was prepared from I4-to I5-day-old C3H/HeJ or BALB/c embryos by trypsin dispersion, using 0.25 % trypsin in mouse osmolarity buffered saline (MOBS; Sheridan & Finlay~Jones, 1977) . Cells were grown in medium 199 as described in the preceding section. Maintenance medium contained only 2 % FCS.
Plaque assay. A plaque assay for human cytomegalovirus (D. J. Lang, personal communication) was adapted for use with murine cytomegalovirus. Secondary cultures of MECC were seeded into wells of Linbro Disposotrays (FB r 6-24TC ) 24 h prior to virus assay. Cells were washed with o'5 ml of MOBS, and o.I ml of maintenance medium was added to each well. Virus was then diluted in maintenance medium and o. I ml of each dilution added to wells in duplicate or triplicate. Virus was allowed to absorb at 37 °C for I h and then the inoculum was removed. Two mI of 2 ~oo methylcellulose in maintenance medium was added to each well, and the trays incubated for 5 days at 37 °C. After staining with methylene blue plaques were counted under IO x magnification; they were seen as dark blue staining areas. Thioglycollate broth (Brewer) . This was purchased from Oxoid, London. Mice received 2 ml of thioglycollate broth intraperitoneally and control mice received 2 ml of MOBS.
Route of inoculation.
Statistical analyses. Statistical analyses were performed using X z test with the Yates' correction factor.
RESULTS
A survey of the resistance patterns of seven inbred strains of mice to i.p. inoculation with approx, lO s p.f.u, of MCMV is shown in Fig. I . Two strains C3H/HeJ and CBA were relatively resistant whereas the remaining five strains, BALB/c, C57BL, DK-BLACK, Simpson and Prince Henry Inbred, were relatively susceptible. A resistant strain C3H/HeJ, and a susceptible strain BALB/c, were chosen for further study.
O ;> .> Resistance to MCMV linked to H-2 complex IO9
/l___ 100 A comparison of the resistance of C3H/HeJ (hereafter referred to as C3H) and BALB/c mice to i.p. inoculation with various doses of MCMV is shown in Fig. 2 . The highest dose available, 8 x io 5 p.f.u., killed only 5 ~ of the C3 H mice and these mice were completely resistant to 4 x io 5 p.f.u. In contrast only 1.6 x io 5 p.f.u, killed Too ~ of the BALB]c mice, and 8 x Io 4 p.f.u, killed more than half of them. It should be noted, however, that there was a very narrow range (only fourfold) between a dose which killed all of the BALB/c mice, 1.6 x Io 5 p.f.u., and that which killed none of them, 4 x I@ p.f.u. This has also been observed in other strains of mice (Setgrade & Osborn, I974) . At the youngest age tested (2I days old) C3H mice were more resistant to i.p. inoculation with MCMV than aI-day-old BALB/c mice or adult BALB/c mice, the same dose of virus killing I6 ~, 92 ~ and Ioo ~ of these mice respectively. Fig. z also shows that the F1 hybrid between C3 H and BALB/c mice has a susceptibility which is intermediate to that of both parents, being able to resist a dose (8 x tO p.f.u.) which killed more than half the BALB[c mice but being susceptible to a dose (4 x io s p.f.u.) which did not kill any C3 H mice. This intermediate resistance of the F1 hybrid suggests that the genes controlling resistance may be partially dominant.
The effect of the route of inoculation on resistance to MCMV was determined in C3H and BALB]c mice (Table I) . C3 H mice were resistant to all routes of inoculation used, that is, s.c., i.p., i.n., and i.e., whereas BALB/c mice were susceptible to i.p. and i.e. inoculation but were resistant to s.c. and i.n. inoculation.
The two resistant strains in the initial survey, C3H and CBA, both had the H-a k genotype whereas susceptible mice were H-2 ~ (BALB/c), H-2 b (C57BL), or of unknown H-2 type. To determine if the resistance was H-2 associated, the effect of various doses of MCMV, administered i.p., was studied in congenic strains of BALB/c mice carrying H-2 b, H-2 g, or H-2 k alleles rather than the H-2 d allele of the normal BALB/c mouse. The results are shown in susceptible to 7"5 × Io5 p.f.u., but were completely resistant to 2" 5 × IO 5 p.f.h. Thus resistance to MCMV appeared to be associated with the possession of the H-2 k allele. MCMV was found to be able to replicate to the same extent in MECC derived from C3H, BALB/c H-2 b, BALB/c H-2 d, BALB/c H-2~ or BALB/c H-2 k mice.
The macrophage had been implicated as being important in host defence against MCMV (Selgrade & Osborn, 1974) . Accordingly known macrophage activators, thioglycollate broth and BCG, were used in an attempt to protect susceptible mice. Thioglycollate broth was given to 8-week-old BALB/c mice 48 h prior to challenge with approx, five times a' minimum lethal dose' of virus. Only 2fl4 mice died compared with I5/I5 control mice. This difference was significant with P < o.oI. Seven-week-old BALB/c mice received one dose of BCG 3, 7 or 2I days before challenge with a 'minimum lethal dose' of virus. Previous work in our * The difference between the number of deaths in groups I and 3 was significant with P < o-ol.
department had shown that administration of one dose of BCG i.p. in BALB/c mice resulted in an increased phagocytic activity of macropbages with a sharp peak on day 3 and a broader peak from days I5 to 25 (M. R. Houghton, personal communication). BCG given 3 or 7 days before MCMV failed to protect mice from lethal infection, and when given 2I days before virus, only 3/IO mice died compared to 9/Io controls, but this difference was not statistically significant. To try to evaluate the role of interferon, endotoxin, a known interferon inducer, was given to I I-week-old BALB/c mice 24 h before virus. However, pre-treatment with endotoxin did not protect mice from lethal infection with MCMV.
Resistant izhweek-old C3H mice were given cyclophosphamide by two different regimes. For the first regime, 4z'5 mg/kg was given to each animal by the s.c. route 48 h after inoculation of virus. Berenbaum & Brown 0964) had found that this regime decreased antibody production to T.A.B. vaccine to a minimum. Our results are shown in Table a. Mice which had received cyclophosphamide were significantly more susceptible to MCMV infection than (Table 3) .
DISCUSSION
The results show that resistance to MCMV is controlled by gene(s) in the H-2 complex. Similarly, resistance to the oncogenic effects of the herpesvirus, Marek's disease virus, has been found to be associated with the major histocompatibility complex in its natural host, the chicken (Longenecker et aL 1976) . Our results contrast with the finding of Lopez (I975) that resistance of mice to the related herpes simplex virus (HSV) was not associated with H-2 type. It should be noted, however, that the mouse is not the natural host of HSV and that susceptibility to HSV in man has been found to be associated with a particular HLA type (Russell & Schlaut, I975) .
Host factors involved in resistance to virus infections have been discussed in detail elsewhere (Mims, 1964; Baron, I97o; Allison, I974) . A host may be resistant to a virus if the virus cannot replicate in the tissues and particularly in the macrophages of the host, or if the host immune and interferon response can prevent the spread of the virus to susceptible target organs or within the target organs themselves.
The ability of macrophages to support virus replication which underlies the differences in susceptibility of various mouse strains to mouse hepatitis virus (Bang & Warwick, 196o ) and West Nile virus (Theis & Koprowski, I96I) does not seem to be the basis of the variation in susceptibilities of mice to MCMV. Selgrade & Osborn (1974) found that MCMV replicated to the same extent in macrophages from resistant CBA and susceptible C57BL mice and our preliminary results suggest that this is also true for macrophages from BALB/c and C3H mice. We have also found that MCMV can replicate to the same extent in MECC derived from susceptible and resistant strains. These findings suggest that it may be the ability of the host to prevent virus spread which is the basis of the resistance of some strains to MCMV.
The mononuclear phagocyte plays a major role in preventing the spread of virus within, and to susceptible target organs (Mims, i964; Allison, I974) . This functional capacity of macrophages develops with age, as does resistance to MCMV (Mannini & Medearis, I960, and hence may account for the susceptibility to this virus of newborn and weanling mice (Selgrade & Osborn, I974) . The ability of macrophages from different strains to prevent spread of MCMV could well account for their differing susceptibilities to the virus. This possibility is supported by our finding that a macrophage activator, thioglycollate broth, increased the resistance to MCMV of a susceptible strain and the finding of Selgrade & Osborn 0974) that a macrophage poison, silica, increased the susceptibility to this virus of I 13 a resistant strain. Whether the effect of pre-treatment with cyclophosphamide in increasing the susceptibility of resistant C3H mice was mediated by its action on macrophages or on some other component of the immune system is not known. The macrophage activator BCG has been shown to protect newborn mice from a lethal infection with HSV when administered 7 days before infection (Starr et al. I976) , but this regime failed to protect BALB]c mice from a lethal MCMV infection. However, BCG given z1 days before infection with MCMV appeared to increase the resistance of BALB/c mice but the numbers of mice available were too small for this resistance to be statistically significant.
Antibody is another factor which prevents virus spread, particularly extracellular spread. This mechanism of resistance to virus infection is not thought to be important in infections with cytomegaloviruses. Indeed, the human foetus may be infected despite the presence of maternal antibodies (Hanshaw, I968 ). Cytomegaloviruses are usually cell-associated and antibody cannot penetrate cells to neutralize them. Furthermore it is unlikely that by 6o h after a primary infection, resistant mice had prcduced enough antibody to protect themselves from an infection which is already lethal in susceptible mice. Thus although the immune response genes in the H-2 region have been shown to regulate antibody responses to a variety of antigens (Gtinther, I973), it does not appear that a difference in the level of antibody production to MCMV between congenic strains of BALB/c mice could account for their differing susceptibilities to MCMV. The increase in susceptibility to MCMV of C3H mice after post-treatment with cyclophosphamide was unlikely to be due to its effect on antibcdy production. This agent affects all dividing cells and even at this dose may have been affecting the function of macrophages and other cells.
Interferon is produced very rapidly in virus infections and can be an important factor in host defence (Baron, I97o) . However the classical or type I interferon (Youngner & Salvin, I973) , such as is induced by Newcastle disease virus, is thought not to be important in infections with cytomegaloviruses (Glasgow et al. I967) . MCMV is a poor inducer of this type of interferon (Osborn & Medearis, I966) and is relatively insensitive to its antiviral effect (Oie et al. I975) . Endotoxin and BCG both induce the production of type I interferon in non-immunized mice, yet were unable to protect BALB/c mice from lethal infection with MCMV. Furthermore, both BALB/c and C3H mice have been shown to be genetically low producers of this type of interferon I968) . Thus it appears unlikely that type I interferon production is the basis of the resistance of some strains to MCMV. Recently the production of immune or type II interferon (VaUe et al. I975b) has been described in infections with other herpesviruses (Valle et al. I975a; Haar, Rasmusson & Merigan, I976; Babiuk & Rouse, I976) but this type of interferon has not yet been described in infections with cytomegaloviruses nor in any primary infection.
In conclusion we report the association between resistance to MCMV and partly dominant gene(s) linked to the H-2 region. Studies are currently in progress to determine the number and subregional location of these genes. The mechanism underlying the variation in resistance to MCMV between strains appears to be a difference in the host immune response to the virus, but there is no evidence as yet to indicate which arm of the response is primarily involved although some function of the macrophage may be implicated. We are at present comparing various components of the immune response to MCMV in resistant and susceptible strains and these results, together with others from studies determining the exact cause of death in susceptible mice, should provide a better understanding of the mechanism controlling resistance.
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